loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Amphetamine

    Client Email Product
    Menu

    Amphetamine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,924Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 204326 / DOSAGE - TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 6.3MG BASE

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AMPHETAMINE(UNII: CK833KGX7E)
    (AMPHETAMINE - UNII:CK833KGX7E)     		AMPHETAMINE12.5mg | 9.4mg | 18.8mg | 15.7mg | 6.3mg | 3.1mg

    Inactive Ingredients

    Ingredient Name
    Neos Therapeutics Brands, LLC
    CITRIC ACID MONOHYDRATE(2968PHW8QP)
    CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK)
    FRUCTOSE(6YSS42VSEV)
    MAGNESIUM STEARATE(70097M6I30)
    MANNITOL(3OWL53L36A)
    METHACRYLIC ACID(1CS02G8656)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
    SILICON DIOXIDE(ETJ7Z6XBU4)
    SODIUM POLYSTYRENE SULFONATE(1699G8679Z)
    SUCRALOSE(96K6UQ3ZD4)
    TRIETHYL CITRATE(8Z96QXD6UM)